| [1] |
Nold MF, Nold-Petry CA, Zepp JA, et al. IL-37 is a fundamental inhibitor of innate immunity[J]. Nat Immunol, 2010, 11(11): 1014-1022.
|
| [2] |
Gao WT, Kumar S, Lotze MT, et al. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity[J]. J Immunol, 2003, 170(1): 107-113.
|
| [3] |
Xu WD, Zhao Y, Liu Y. Insights into IL-37, the role in autoimmune diseases[J]. Autoimmun Rev, 2015, 14(12): 1170-1175.
|
| [4] |
Quirk S, Agrawal DK. Immunobiology of IL-37: mechanism of action and clinical perspectives[J]. Expert Rev Clin Immunol, 2014, 10(12): 1703-1709.
|
| [5] |
Chen B, Huang K, Ye L, et al. Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity[J]. J Transl Med, 2015, 13(13): 36-44.
|
| [6] |
Ding L, Hong X, Sun B, et al. IL-37 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells[J/OL]. Sci Rep, 2017, 7(1): 11601. doi: 10.1038/s41598-017-11397-5. |
| [7] |
Banchereau J, Pascual V, O’garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines[J]. Nat Immunol, 2012, 13(10): 925-931.
|
| [8] |
Zhao PW, Jiang WG, Wang L, et al. Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis[J/OL]. PLoS One, 2014, 9(5): e95346. doi: 10.1371/journal.pone.0095346.eCollection2014. |
| [9] |
Liu L, Xue Y, Zhu YF, et al. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout[J]. Arthritis Res Ther, 2016, 18(1): 268-282.
|
| [10] |
Zeng M, Dang W, Chen B, et al. IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response[J]. Clin Rheumatol, 2015, 35(9): 2251-2258.
|
| [11] |
Boraschi D, Lucchesi D, Hainzl S, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family[J]. Eur Cytokine Netw, 2011, 22(3): 127-147.
|
| [12] |
Ellisdon AM, Nold-Petry CA, D’andrea L, et al. Homodimerization attenuates the anti-inflammatory activity of interleukin-37[J/OL]. Sci Immunol, 2017, 2(8):1548. doi： 10.1126/sciimmunol.aaj1548. |
| [13] |
Nold-Petry CA, Lo CY, Rudloff I, et al. IL-37 requires the receptors IL-18 Ralpha and IL-1R 8(SIGIRR)to carry out its multifaceted anti-inflammatory program upon innate signal transduction[J]. Nat Immunol, 2015, 16(4): 354-365.
|
| [14] |
Sharma S, Kulk N, Nold MF, et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines[J]. J Immunol, 2008, 180(8): 5477-5482.
|
| [15] |
Akdis M, Burgler S, Crameri R, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases[J]. J Allergy Clin Immunol, 2011, 127(3): 701-721.
|
| [16] |
Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease[J]. Immunology, 2010, 129(3): 311-321.
|
| [17] |
Zhang W, Cong XL, Qin YH, et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis[J]. Inflammation, 2013, 36(1): 103-109.
|
| [18] |
Shao XT, Feng L, Gu LJ, et al. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis[J]. Clin Exp Med, 2009, 9(3): 215-221.
|
| [19] |
Chovanova L, Vlcek M, Krskova K, et al. Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis[J]. Gen Physiol Biophys, 2013, 32(3): 395-404.
|
| [20] |
Yang LB, Zhang J, Tao JA, et al. Elevated serum levels of interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis[J]. APMIS, 2015, 123(12): 1025-1031.
|
| [21] |
Song LJ, Wang YQ, Sui YM, et al. High interleukin-37 (IL-37) expression and increased mucin-domain containing-3 (TIM-3) on peripheral T cells in patients with rheumatoid arthritis[J]. Med Sci Monit, 2018, 8(24): 5660-5667.
|
| [22] |
Ragaba D, Mobasher S, Shabaan E. Elevated levels of IL-37 correlate with T cell activation status in rheumatoid arthritis patients[J]. Cytokine, 2019, 113(18): 305-310.
|
| [23] |
Xia LP, Shen H, Lu J. Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: attenuated the production of inflammatory cytokines[J]. Cytokine, 2015, 76(2): 553-557.
|
| [24] |
Hahn M, Frey S, Hueber AJ. The novel interleukin-1 cytokine family members in inflammatory diseases[J]. Curr Opin Rheumatol, 2017, 29(2): 208-213.
|
| [25] |
Pei B, Xu S, Liu T, et al. Associations of the IL-1F7 gene polymorphisms with rheumatoid arthritis in Chinese Han population[J]. Int J Immunogenet, 2013, 40(3): 199-203.
|
| [26] |
Limón-Camacho L, Vargas-Rojas M, Vázquez-Mellado J, et al. In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis[J]. J Rheumatol, 2012, 39(4): 830-835.
|
| [27] |
Fawzy RM, Ganeb SS, Said EA, et al. Serum level of interleukin-37 and expression of its mRNA in ankylosing spondylitis patients：possible role in osteoporosis[J]. Egypt J Immunol, 2016, 23(1): 19-29.
|
| [28] |
|
| [29] |
Klein-Wieringa IR, Lange-Brokaar LB, Yusuf E, et al. Inflammatory cells in patients with endstage knee osteoarthritis：a comparison between the synovium and the infrapatellar fat pad[J]. J Rheumatol, 2016, 43(4): 771–778.
|
| [30] |
Berenbaum F. Osteoarthritis as an inflammatory disease(osteoarthritis is not osteoarthrosis！)[J]．Osteoarthritis Cartilage, 2013, 21(1): 16-21.
|
| [31] |
Weber A, Chan P, Wen C. Do immune cells Lead the way in subchondral bone disturbance in osteoarthritis？[J]. Prog Biophys Mol Biol, 2017, 12(17): 30181-30185. doi: 10.1016/j.pbiomolbio. |
| [32] |
Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis[J]. Nat Rev Rheumatol, 2011, 7(1): 33-42.
|
| [33] |
Daheshia M, Yao JQ. The interleukin 1 beta pathway in the pathogenesis of osteoarthritis[J]. Rheumatology, 2008, 35(12): 2306-2312.
|
| [34] |
van Geffen EW, van Caam A, Schreurs W, et al. IL-37 diminishes proteoglycan loss in human OA cartilage: donor-specific Link between IL-37 and MMP-3[J]. Osteoarthritis Cartilage, 2019, 27(1): 31440-31447.
|
| [35] |
Cavalli G, Koenders M, Kalabokis V, et al. Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation[J]. Rheumatology, 2016, 55(12): 2220-2229.
|
| [36] |
Jy Y, Fau-An YJ, An JM, et al. Mutation analysis of the Smad3 gene in human osteoarthritis[J]. Eur J Hum Gene, 2003, 11(9): 714-717.
|
| [37] |
Grimsby S, Jaensson H, Dubrovska A, et al. Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms acomplex with Smad3 and inhibits its transcriptional activity[J]. FEBS Lett, 2004, 577(1-2):93-100.
|